These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18385395)

  • 1. Leflunomide therapy in kidney transplantation: ready for prime time?
    Mannon RB
    Clin J Am Soc Nephrol; 2008 May; 3(3):652-3. PubMed ID: 18385395
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.
    Leca N; Muczynski KA; Jefferson JA; de Boer IH; Kowalewska J; Kendrick EA; Pichler R; Davis CL
    Clin J Am Soc Nephrol; 2008 May; 3(3):829-35. PubMed ID: 18372319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK virus nephropathy and kidney transplantation.
    Bohl DL; Brennan DC
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S36-46. PubMed ID: 17699509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
    Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
    Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.
    Cuellar-Rodriguez J; Stephany B; Poggio E; Mossad SB; Goldfarb D; Lard M; Askar M; Fatica R; Srinivas T; Braun W; Shoskes D; Flechner S; Schmitt SK; Shrestha R; Avery RK
    Clin Transplant; 2013; 27(3):E230-6. PubMed ID: 23551281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BK viral disease in renal transplantation.
    Cannon RM; Ouseph R; Jones CM; Hughes MG; Eng M; Marvin MR
    Curr Opin Organ Transplant; 2011 Dec; 16(6):576-9. PubMed ID: 22027587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.
    Canivet C; Rostaing L; Galvani S; Böhler T; Gandia P; Mengelle C; Guilbeau-Frugier C; Thomsen M; Salvayre R; Negre-Salvayre A; Kamar N
    Int Immunopharmacol; 2009 Aug; 9(9):1131-6. PubMed ID: 19446045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide use in renal transplantation.
    Leca N
    Curr Opin Organ Transplant; 2009 Aug; 14(4):370-4. PubMed ID: 19512928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of renal allograft polyoma BK virus infection with leflunomide.
    Josephson MA; Gillen D; Javaid B; Kadambi P; Meehan S; Foster P; Harland R; Thistlethwaite RJ; Garfinkel M; Atwood W; Jordan J; Sadhu M; Millis MJ; Williams J
    Transplantation; 2006 Mar; 81(5):704-10. PubMed ID: 16534472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
    Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
    Krisl JC; Taber DJ; Pilch N; Chavin K; Bratton C; Thomas B; McGillicuddy J; Baliga P
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):1003-9. PubMed ID: 22461534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BK virus in the kidney transplant patient.
    Kuppachi S; Thomas B; Kokko KE
    Am J Med Sci; 2013 Jun; 345(6):482-8. PubMed ID: 23698093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsy-Proven BK Virus-Associated Nephropathy: Clinico-Pathologic Correlations.
    Jahdali S; Al Oudah N; Alsaad KO; Kfoury H; Qurashi S; Al Sayyari A
    Exp Clin Transplant; 2017 Jun; 15(3):289-294. PubMed ID: 28137206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide for polyomavirus type BK nephropathy.
    Williams JW; Javaid B; Kadambi PV; Gillen D; Harland R; Thistlewaite JR; Garfinkel M; Foster P; Atwood W; Millis JM; Meehan SM; Josephson MA
    N Engl J Med; 2005 Mar; 352(11):1157-8. PubMed ID: 15784677
    [No Abstract]   [Full Text] [Related]  

  • 19. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
    Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.